NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM)

Clinical trials for NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) explained in plain language.

Never miss a new study

Get alerted when new NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) trials appear

Sign up with your email to follow new studies for NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1

New hope for myeloma patients: trial tests promising drug combinations

Disease control Not yet recruiting

This study is comparing two different drug combinations for people newly diagnosed with multiple myeloma who are not eligible for stem cell transplant. About 160 participants will receive either elranatamab or daratumumab, both combined with three other standard myeloma drugs. Th…

Matched conditions: NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM)

Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM)

Get alerted when new NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) trials appear

New hope for myeloma patients: trial tests promising drug combinations